Riskpilot← Back to searchSign inGet full accessRosco Diagnostica ApS
APSActiveCVR 27210341Stensmosevej 24AManufacture of other chemical products n.e.c. · NACE 2059Est. 20035 employeeswww.rosco-diagnostica.com
Revenue 2025
DKK 1,5M
+43% vs 2024
EBITDA margin
-35.5%
+16% vs 2024
Equity ratio
21.0%
Financial strength
Net profit 2025
DKK -649K
+21% vs 2024
| Revenue | DKK 1,5M | +43% |
| EBITDA | DKK -537K | +16% |
| Net profit | DKK -649K | +21% |
| Total assets | DKK 2,3M | +1% |
| Equity | DKK 489K | -57% |
| Employees | 5 | — |
Legal name
Rosco Diagnostica ApS
CVR number
27210341
Legal form
Anpartsselskab
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
6. juni 2003
Share capital
DKK 600.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den Administrerende direktør.
Company purpose
Selskabets formål er at producere og forhandle diagnostiske tabletter samt relevante procesværktøjer til laboratorier i Danmark og udlandet.
Address
Stensmosevej 24A
Phone
+4593406565
Email
san@rosco-diagnostica.com
Website
www.rosco-diagnostica.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -3.231 | 6.147 | 6.277 | 5.218 | 5.918 | 5.374 | 5.734 | 4.194 | 3.421 | 3.401 | 3.637 | 1.630 | 2.670 | 1.055 | 1.513 |
| Staff expenses | -2.767 | -2.178 | -5.840 | -3.477 | -3.170 | -4.041 | -3.909 | -3.594 | -3.713 | -2.830 | -3.185 | -2.588 | -615 | -1.697 | -2.049 |
| EBITDA | -400 | 3.969 | 436 | 1.741 | 2.748 | 1.333 | 1.825 | 599 | -293 | 571 | 452 | -959 | 2.055 | -642 | -537 |
| Depreciation & amort. | -32 | 29 | -25 | 101 | 132 | -155 | -163 | -267 | -227 | -199 | -180 | -168 | -121 | -94 | -65 |
| EBIT | -432 | 3.940 | 412 | 1.641 | 2.617 | 1.178 | 1.661 | 332 | -520 | 371 | 272 | -1.127 | 1.934 | -736 | -602 |
| Net financials | -159 | -23 | 58 | -34 | -9 | 26 | 40 | 2 | -146 | -180 | -87 | -6.508 | -52 | -85 | -48 |
| Profit before tax | -351 | 3.917 | 469 | 1.607 | 2.608 | 1.204 | 1.701 | 334 | -666 | 192 | 184 | -7.635 | 1.882 | -820 | -649 |
| Tax | 21 | -0 | -0 | -0 | 482 | 277 | 380 | 69 | -317 | 46 | 92 | -65 | -0 | -0 | -0 |
| Net profit | -372 | 3.917 | 469 | 1.607 | 2.126 | 927 | 1.321 | 266 | -349 | 146 | 92 | -7.570 | 1.882 | -820 | -649 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 6.902 | 9.504 | 7.548 | 7.355 | 9.210 | 10.072 | 10.235 | 9.638 | 9.752 | 10.428 | 4.193 | 2.378 | 2.298 | 2.330 |
| Equity | — | 5.386 | 2.712 | 3.118 | 5.244 | 6.171 | 7.493 | 7.758 | 7.409 | 7.554 | 7.646 | 77 | 1.958 | 1.138 | 489 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 1.190 | 1.248 | 1.242 | 1.091 | 811 | 667 | 31 | 0 | 0 |
| Short-term debt | 0 | 1.516 | 4.293 | 3.230 | 2.111 | 3.038 | 1.390 | 1.160 | 988 | 1.107 | 1.906 | 2.643 | 389 | 1.160 | 1.842 |
| Total debt | 0 | 1.516 | 6.793 | 4.430 | 2.111 | 3.038 | 2.580 | 2.408 | 2.230 | 2.198 | 2.717 | 3.310 | 419 | 1.160 | 1.842 |
EBITDA margin
-35.5%
This company
15.8%
Market median
-325% vs market
20122025
Equity ratio
21.0%
This company
38.2%
Market median
-45% vs market
20122025
Return on equity
-132.9%
This company
18.4%
Market median
-822% vs market
20122025
Net profit margin
-42.9%
This company
8.1%
Market median
-630% vs market
20122025
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20122025
Debt / equity
3.77×
This company
0.62×
Market median
-508% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-05-01 – 2023-12-31
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-05-01 – 2016-04-30
- Annual report 2015Filed via CVR / Virk · Period 2014-05-01 – 2015-04-30
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PR Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
Jd Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
OR Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
JT Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
MR Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
SA Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
LH Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
ED Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
BL Unofficial title | Unofficial title | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2012 | — | — | |
| Chairman | 2011 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2008 | — | — | |
| Board of Directors | 2010 | — | — | |
| Chairman | 2019 | — | — | |
| Chairman | 2010 | — | — | |
| Board of Directors | 2017 | — | — | |
| Deputy Chairman | 2015 | — | — | |
| Chairman | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Alpine-Bio ApS | Company | 100.0% | 100.0% | 2024 |
P. REUMERT HOLDING ApS | Company | 50.0% | 50.0% | 2015 |
ROSCO HOLDING ApS | Company | 33.3% | 33.3% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
S21 Holding ApS
Rosco Diagnostica ApS Board members of Rosco Diagnostica ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Reumert | Chief Executive Officer | 0 companies |
| Jørgen de Muzquiz Reumert | Chief Executive Officer | 0 companies |
| Ole Reumert | Chief Executive Officer | 0 companies |
| Jesper Thøfner | Chief Executive Officer | 0 companies |
| Mogens Riber | Chief Executive Officer | 0 companies |
| Søren Anker Nielsen | Chief Executive Officer | 0 companies |
| Louise Hebert | Chief Executive Officer | 0 companies |
| Ebba Dorrit Reumert | Chief Executive Officer | 0 companies |
| Bo Lauritzen | Unofficial title | 0 companies |
| Erling Andersen | Board of Directors | 0 companies |
| Joakim Kirk Werner | Board of Directors | 0 companies |
| Tina Bogut | Board of Directors | 0 companies |
| Bent Kløcker Kierkegaard | Chairman | 0 companies |
| Tyge Jesper Rothe | Chairman | 0 companies |
| Jakob Kristensen | Board of Directors | 0 companies |
| Per Regnarsson | Chairman | 0 companies |
| Camilla Kisling | Board of Directors | 0 companies |
| Peter Ejmund Samuelsen | Chairman | 0 companies |
| Lars Lund-Nielsen | Chairman | 0 companies |
| Christian Stricker | Board of Directors | 0 companies |
| Anne Bagger Hansen | Deputy Chairman | 0 companies |
| Kaj Kvist Nielsen | Chairman | 0 companies |